USG Awards Pharmaceutical Company Funds To Develop Ebola Treatment
The Hill: Feds award company up to $35M to develop Ebola drug
“The Department of Health and Human Services (HHS) on Tuesday awarded about $12 million to a North Carolina pharmaceutical company that has been developing Ebola treatments. The company, BioCryst Pharmaceuticals, has created a ‘promising’ experimental drug that prevents the Ebola virus from reproducing; it has been effective in preliminary studies, according to a release Tuesday…” (Ferris, 3/31).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.